THIRD-PARTY TESTED · COA AVAILABLE◆FREE U.S. SHIPPING ON ORDERS $200+◆SHIPS IN 24–48 BUSINESS HOURS◆DISCREET, PROTECTIVE PACKAGING◆RESEARCH USE ONLY◆THIRD-PARTY TESTED · COA AVAILABLE◆FREE U.S. SHIPPING ON ORDERS $200+◆SHIPS IN 24–48 BUSINESS HOURS◆DISCREET, PROTECTIVE PACKAGING◆RESEARCH USE ONLY◆
Tirzepatide 20mg, a synthetic dual GIP/GLP-1 receptor agonist peptide for in-vitro research. Lyophilized, third-party tested, COA available. Research use only.
Tier
Quantity
Discount
Basic
3-4 units
5% off
Most Popular POPULAR
5-9 units
10% off
Max Savings
10+ units
12% off
Bulk discounts apply automatically in your cart.
Third-Party TestedCertificate of Analysis published
COA-Backed Quality — if a delivered item is damaged, defective, or incorrect, contact us within 48 hours and we'll make it right per our Refund & Return Policy.
For Research Use Only. Not intended for human consumption, veterinary use, or any clinical application, sold exclusively for laboratory and in-vitro research. By purchasing, you confirm you are a qualified researcher.
Secure Checkout
VISAMastercardAMEXDiscover SSL Secured
Category
Peptides
Purity
High purity (research grade)
Storage
Refrigerate at 2–8°C
Form
Lyophilized powder
Shipping
Ships in 24–48 business hours · discreet
Overview
About Tirzepatide 20mg
Tirzepatide 20mg is a synthetic 39-amino-acid peptide supplied by Echo Peptides strictly for in-vitro laboratory research. Structurally, it is engineered as a single molecule that engages two incretin targets at once — the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor — making it a useful reference compound for researchers probing dual-agonist pharmacology in cell-culture and preclinical metabolic systems.
Its extended stability in research models is attributed to defined structural modifications, including non-natural aminoisobutyric acid (Aib) residues that resist enzymatic cleavage and a C20 fatty diacid chain that supports albumin binding. Because a single sequence spans two receptor families, laboratories frequently use Tirzepatide to compare unimolecular multi-receptor engagement against single-target GLP-1 analogs when characterizing incretin signaling in vitro.
Key research areas
Metabolic regulation and incretin signaling pathways
Glucose homeostasis and insulin secretion mechanisms in cell-culture models
Energy balance and gastric-emptying research paradigms
Multi-receptor (GIP/GLP-1) agonism in preclinical metabolic studies
Specifications
Amount: 20mg
Form: Lyophilized white powder
Modifications: Lipidated with a C20 fatty diacid chain; Aib residues for enhanced stability
Molecular weight: 4813.5 g/mol
Solubility: Soluble in bacteriostatic water for research use
Storage: Refrigerate at 2–8°C; long-term stability when lyophilized
Each batch is third-party tested for identity and purity, and a Certificate of Analysis is available. This material is intended for in-vitro laboratory research use only — not for human or veterinary use, and not for diagnostic or therapeutic purposes.
Regulatory notice. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease, and not for human or veterinary use. Sold exclusively for laboratory and in-vitro research by qualified professionals — always follow proper laboratory safety protocols.
This vial
Working with the 20mg vial
This vial contains 20 mg of lyophilized material. Reconstitution does not change that mass — it changes the volume it occupies — so the concentration you end up with is set entirely by how much diluent you add.
Diluent added
Concentration
Concentration
Molarity
1 mL
20 mg/mL
20000 µg/mL
4.15 mM
2 mL
10 mg/mL
10000 µg/mL
2.08 mM
3 mL
6.67 mg/mL
6667 µg/mL
1.38 mM
5 mL
4 mg/mL
4000 µg/mL
0.831 mM
Molarity uses this compound's verified molecular weight of 4813.5 g/mol.
Available sizes of Tirzepatide
Each strength is stocked and documented separately. Cost per mg is shown so the sizes can be compared directly.
Figures are unit conversions for handling reference material in vitro. Nothing here is a dose or a protocol.
Frequently Asked Questions
What is Tirzepatide 20mg as a research compound?
It is a synthetic 39-amino-acid peptide (~4810 Da) that acts as a dual agonist at both the GIP and GLP-1 receptors within a single molecule. Structural features such as Aib residues and a C20 fatty diacid chain give it enhanced stability in research models, which makes it a common reference compound for studying unimolecular multi-receptor incretin pharmacology in vitro.
What do laboratories study Tirzepatide 20mg for?
Researchers use it in cell-culture and preclinical models to investigate incretin signaling pathways, glucose homeostasis and insulin-secretion mechanisms, energy-balance and gastric-emptying paradigms, and how simultaneous GIP/GLP-1 agonism differs from single-target GLP-1 analogs. All work is strictly in-vitro and non-clinical.
How is Tirzepatide 20mg supplied, stored, and verified?
It ships as a 20mg lyophilized white powder that is soluble in bacteriostatic water for research use. Store refrigerated at 2–8°C, with long-term stability retained while lyophilized. Each batch is third-party tested for identity and purity, and a Certificate of Analysis is available on request.
